Alimetry Ltd.
PrivateLast Round
Series A
Extension
Oct 29, 2024
Total Funding Raised
$29.06M
Company Overview
Alimetry Ltd. is a medtech company that develops a non-invasive wearable medical device, Gastric Alimetry, to aid in the diagnosis of various gastric disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alimetry Ltd. Comps
Public and private peers based on sector, stage, and business model.
Alimetry Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 29, 2024 | ||||
| Series A | Mar 3, 2022 | ||||
| Seed | Apr 20, 2021 |
Key People
Founding team and executive leadership
Alimetry Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Icehouse Ventures | Series A Extension |
| Olympus Innovation Ventures | Series A Extension |
| IP Group | Series A, Series A Extension, Seed |
| K1W1 | Series A, Series A Extension |
| Movac | Series A Extension, Series A |
Alimetry Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alimetry Ltd.'s valuation, stock price, and market status.